The Israel Journal of Veterinary Medicine, published by the Israel Veterinary Medical Association, serves as a vital resource for researchers, professionals, and students in the fields of veterinary medicine and animal science. With a commitment to advancing knowledge across diverse veterinary disciplines, this journal plays a crucial role in disseminating significant findings and innovations that influence both local and global veterinary practices. Although it currently holds a Q4 ranking in both the Animal Science and Zoology and Veterinary (miscellaneous) categories, the journal's open access policy, enabling free availability of articles, aspires to increase its accessibility and engagement among the academic community. The journal's convergence of research from 2007 to 2024 showcases its dedication to continuously contributing to the evolving landscape of veterinary science.

Clinical and Experimental Emergency Medicine, published by the SEOUL KOREAN SOCIETY OF EMERGENCY MEDICINE, is a premier Open Access journal dedicated to advancing knowledge and practice within the fields of emergency medicine and emergency nursing. With an ISSN of 2383-4625 and an E-ISSN of 2383-4625, this journal has established itself prominently in the academic community, achieving a notable Q2 ranking in both Emergency Medicine and Emergency Nursing categories in 2023. The journal is committed to providing highly relevant research, innovative clinical practices, and educational resources that address the urgent and evolving challenges in emergency care. With a vision to foster collaboration among researchers, practitioners, and students, it aims to contribute significantly to the body of knowledge that enhances emergency medical services and improves patient outcomes globally. Accepting submissions and offering Open Access since its inception in 2014, the journal is positioned as a key resource for those dedicated to the advancement of emergency medicine.

International Maritime Health is a distinguished, open-access journal published by VIA MEDICA that has been pivotal in disseminating research related to maritime health since its inception in 1999. With an ISSN of 1641-9251 and an E-ISSN of 2081-3252, the journal focuses on various aspects of Infectious Diseases, Medicine, and Public Health, making significant contributions to environmental and occupational health, particularly in maritime contexts. As of 2023, it enjoys a Q3 ranking in prominent categories, highlighting its relevance and impact in the field, supported by Scopus ranking that places it competitively within its domains. Open access since 2005, International Maritime Health provides researchers, professionals, and students vital resources to understand and tackle health challenges faced in maritime environments, facilitating the exchange of knowledge that is crucial for enhancing health outcomes in this unique sector. The journal is based in Gdansk, Poland, emphasizing its global outreach and commitment to addressing maritime health issues.

SAFETY SCIENCE, published by Elsevier in the Netherlands, is a premier international journal dedicated to advancing the fields of safety research, public health, environmental and occupational health, and risk management. With an impressive impact factor and recognized as a Q1 journal in multiple categories for 2023, its rigorous peer-reviewed articles are essential for researchers, professionals, and students alike. The journal covers a wide range of topics designed to influence safety practices and policies globally. Although Open Access options are not available, the substantial insights provided in each issue underscore the journal's critical role in enhancing the understanding of safety and risk dynamics in a constantly evolving world. With a convergence of knowledge from the years 1991 to 2025, SAFETY SCIENCE remains at the forefront of evidence-based research, stimulating essential dialogues and innovations that shape our approach to safety in various domains.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, published by MARY ANN LIEBERT, INC, stands as a premier academic journal dedicated to advancing the field of pediatric psychopharmacology. With a rich history of publication spanning from 1990 to 2024, this journal presents cutting-edge research that informs clinical practices and policy decisions impacting the mental health of children and adolescents. Ranked in the Q2 category for both Pediatrics, Perinatology and Child Health and Pharmacology (medical) as of 2023, it reflects its critical contribution to these fields, along with a respectable Q3 status in Psychiatry and Mental Health. Researchers and practitioners benefit from the journal's rigorous peer-reviewed articles, which delve into the efficacy, safety, and ethical implications of pharmacological treatments tailored for young populations. Although the journal does not currently offer Open Access, it remains a vital resource for anyone engaged in child and adolescent health research and treatment strategies. Its commitment to fostering dialogue and innovation in psychopharmacology ensures its pivotal role in shaping future standards and practices in this essential area of medical science.

The Journal of Occupational Medicine and Toxicology, published by BMC, is a pivotal open access journal that has been at the forefront of advancing knowledge in the fields of workplace health, environmental safety, and toxicology since its inception in 2006. With a robust impact factor and a distinguished reputation, this journal occupies a significant position in academic rankings, including Q2 in Public Health and Occupational Health, and Q1 in both Safety Research and Toxicology for 2023. Renowned for its rigorous peer-review process, it serves as a vital resource for researchers, professionals, and students aiming to disseminate and access high-quality research and innovative practices in occupational health and toxicological studies. Based in the United Kingdom, the journal prioritizes global access to research, ensuring that critical information reaches a diverse audience, conducive to the advancement of public health and safety. As it converges towards 2024, the journal continues to lead discussions that shape policies and practices related to workforce environments, chemical exposure, and preventative strategies in health management.

Journal of Radiological Protection, published by IOP Publishing Ltd, is a pivotal academic journal dedicated to advancing knowledge in the fields of radiology and radiation protection. Since its inception in 1988 and continuing through to 2024, this journal provides a platform for the dissemination of innovative research and critical reviews that explore the effects of radiation exposure on health and the environment. With an Impact Factor that places it among the Q3 category in Medicine, Public Health, Environmental and Occupational Health, as well as in Waste Management and Disposal, the journal is vital for professionals, researchers, and students keen on understanding the implications of radiological science. The Journal of Radiological Protection aims to contribute to improved practices and policies in radiation safety, making its findings essential for those involved in environmental health and public safety initiatives. Articles are accessible through various academic databases, ensuring widespread dissemination among the scientific community, thereby enhancing the journal's stature and influence in radiological research.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

MEDICAL LETTER ON DRUGS AND THERAPEUTICS is a pivotal resource for professionals in the fields of medicine and pharmacology, published by MED LETTER INC. Since its inception in 1965, this journal has been committed to elucidating the complexities of drug therapy and clinical therapeutics, offering readers evidence-based insights and critical evaluations of the latest medications and treatment protocols. With a quarterly ranking reflecting its stature—Q4 in Medicine (Miscellaneous) and Q3 in both Pharmacology and Pharmacology (Medical)—the journal maintains a specific niche ensuring readers are equipped with updated information that continues to influence healthcare practices. Although it does not operate under an open access model, the journal is accessible to institutions and professionals eager to stay at the forefront of medicinal advancements. The importance of this journal lies in its dedication to enhancing pharmacological knowledge, thus catering to the needs of researchers, healthcare providers, and students alike, making it an essential addition to the literature in therapeutic drug interventions.